University of Thessaly (UTH)
Εκτίμηση της in vivo δραστικότητας των κυματοχρωμάτων P4501A2, P4502A6 και των ενζύμων ν-ακετυλο-τρασφεράση-2 και οξειδάση της ξανθίνης μετά από προσδιορισμό με υγρή χρωματογραφία υψηλής απόδοσης των μεταβολιτών της καφεΐνης στα ούρα ασθενών με χρόνια ηπατική νόσο
Abstract
dc:descriptionCaffeine (1,3,7-trimethylxanthine) is metabolized by CYP1A2, CYP2A6, Xanthine Oxidase and N-acetyltransferase-2 and its major urinary metabolites are 1-methyluric acid (1U), 5-acetylamino-6-formylamino-3-methyluracil (AFMU), 1-methylxanthine (1X), 1,7-dimethyluric acid (17U) and 1,7-dimethylxanthine (17X). CYP1A2, CYP2A6, XO and NAT-2 activities are estimated from the metabolic ratios (AFMU+1U+1X)/17U, 17U/(17U+17X), 1U/(1X+1U) and AFMU/(AFMU+1U+1X), respectively. The aim of the study was the development of a High Performance Liquid Chromatography (HPLC) method for the quantification of caffeine metabolites in urine and the evaluation of the above ratios in 125 healthy and 342 liver disease patients. After a 30-hours xanthine-free and medication-free period 200mg caffeine were administered and a 6-hours spot urine sample was collected. Caffeine metabolites and the Internal Standard were extracted with chloroform/isopropanol (85:15, v/v) and separated on a C18 column using solvent A (0.1% acetic acid–methanol–acetonitrile, 92:4:5, v/v) and solvent B (0.1% acetic acid–methanol, 60:40, v/v), and detected at 280nm. Adequate metabolite separation, accuracy (94.1–106.3%), intraday (8.02%) and interday (8.78%) precision were achieved. Age and gender had no effect on enzymes activity whereas smoking induced CYP1A2 and inhibited CYP2A6. NAT-2 exhibited bimodal distribution with 59.2% of the healthy and 57.0% of the patients being slow acetylators. CYP1A2 and CYP2A6 were suppressed in patients and inhibition was more pronounced in cirrhotics. It was demontstrated, that CYP1A2 was inhibited in autoimmune hepatitis, in non-alcoholic steatohepatitis, in HBV and HCV infection, in alcoholic liver disease and in autoimmune cholostatic liver diseases. Τhe inducing effect of smoking masked the inhibitory effect of disease on CYP1A2 activity, in most patients subgroups, with the exception of alcoholic liver disease and non alcoholic steatohepatitis. Smoking did not mask CYP1A2 inhibition by cirrhosis, due to the pronounced enzyme failure in decompensated patients while no such effect was observed in compensated cirrhotics. XO activity was elevated, especially in virus infected patients. Finally, it was demonstrated that NAT-2 activity was reduced in fast acetylators. The logarithm of the ratio (AFMU+1U+1X)/17U exhibited 70.7-85.4% specificity and 60.1-91.7% sensitivity in the diagnosis of different stages of liver disease, in the non-smokers group. In the smokers group sensitivity was 31.5-83.3% while specificity was 72.1-86.0%. In most cases, the CYP1A2 index was more sensitive than routine tests while the combined use of this ratio and conventional tests improved the detection of liver disease with 69.6-100.0% sensitivity, in non-smokers, and 51.7-83.3% sensitivity in smokers. Caffeine metabolic ratios assessment in spot urine samples is a non-invasive, innocuous and valid procedure for the determination of CYP1A2, CYP2A6, XO and ΝΑΤ-2 activities while the logarithm of the ratio (AFMU+1U+1X)/17U along with conventional liver function tests contributes towards a significant improvement in the diagnosis of liver disease.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Begas, Elias
- Μπέγας, Ηλίας
Subjects
dc:subject × 26- Κυτταροχρώματα P4501A2, P4502A6
- Οξειδάση ξανθίνης
- Ν-ακετυλοτρανσφεράση-2
- Χρόνια ηπατική νόσος
- Υγρή χρωματογραφία υψηλής απόδοσης
- Μεταβολικοί όγκοι καφεΐνης
- Δυναμική δοκιμασία ηπατικής λειτουργίας
- Εξειδίκευση
- Ευαισθησία
- Cytochromes P4501A2, P4502A6
- Xanthine oxidase
- N-acetyltransferase-2
- Chronic liver disease
- High performance liquid chromatography
- Caffeine metabolic ratios
- Dynamic liver function test
- Specificity
- Sensitivity
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27091